APA

Nicholson O., DiCandilo F., Kublin J., Sun X., Quirk E., Miller M., Gray G., Pape J., Robertson M. N., Mehrotra D. V., Self S., Turner K., Sanchez J., Pitisuttithum P., Duerr A., Dubey S., Kierstead L., Casimiro D. & Hammer For The Merck V/Hiv Vaccine Trials Network Study Team S. M. (2011). Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults. : AIDS research and human retroviruses.

Chicago

Nicholson Ouzama, DiCandilo Fay, Kublin James, Sun Xiao, Quirk Erin, Miller Michelle, Gray Glenda, Pape Jean, Robertson Michael N, Mehrotra Devan V, Self Steven, Turner Katherine, Sanchez Jorge, Pitisuttithum Punnee, Duerr Ann, Dubey Sheri, Kierstead Lisa, Casimiro Danilo and Hammer For The Merck V/Hiv Vaccine Trials Network Study Team Scott M. 2011. Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults. : AIDS research and human retroviruses.

Harvard

Nicholson O., DiCandilo F., Kublin J., Sun X., Quirk E., Miller M., Gray G., Pape J., Robertson M. N., Mehrotra D. V., Self S., Turner K., Sanchez J., Pitisuttithum P., Duerr A., Dubey S., Kierstead L., Casimiro D. and Hammer For The Merck V/Hiv Vaccine Trials Network Study Team S. M. (2011). Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults. : AIDS research and human retroviruses.

MLA

Nicholson Ouzama, DiCandilo Fay, Kublin James, Sun Xiao, Quirk Erin, Miller Michelle, Gray Glenda, Pape Jean, Robertson Michael N, Mehrotra Devan V, Self Steven, Turner Katherine, Sanchez Jorge, Pitisuttithum Punnee, Duerr Ann, Dubey Sheri, Kierstead Lisa, Casimiro Danilo and Hammer For The Merck V/Hiv Vaccine Trials Network Study Team Scott M. Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults. : AIDS research and human retroviruses. 2011.